English
中文简体
中文繁体
Company
Overview
Board of Directors
Partnering
Technology
Glycan-specific Conjugation
Alphatecan
Bispecific Antibody
Subcutaneous Formulation
Single-domain Antibody
Publications
Pipeline
Overview
Envafolimab(KN035)
KN026
JSKN003
JSKN016
JSKN033
KN046
KN019
Investors
Information Disclosure
Corporate Governance
Stock Information
Corporate Communications
Email Subscription
News
Press Release
Media Report
Career
Corporate Culture
Job Opportunities
Contact Us
Company
Overview
Board of Directors
Partnering
Technology
Glycan-specific Conjugation
Alphatecan
Bispecific Antibody
Subcutaneous Formulation
Single-domain Antibody
Publications
Pipeline
Overview
Envafolimab(KN035)
KN026
JSKN003
JSKN016
JSKN033
KN046
KN019
Investors
Information Disclosure
Corporate Governance
Stock Information
Corporate Communications
Email Subscription
News
Press Release
Media Report
Career
Corporate Culture
Job Opportunities
Contact Us
English
中文简体
中文繁体
Investors
Information Disclosure
Listing Documents
Financial Reports
Announcements & Circulars
Company Presentation
ESG Reports
Corporate Governance
Stock Information
Corporate Communications
Email Subscription
Announcements & Circulars
The announcement begins in December 2019
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES ON KN046 AND KN026 FOR PRESENTATION AT ESMO CONGRESS 2023
2023-08-10
DATE OF BOARD MEETING
2023-08-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
2023-08-03
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE III CLINICAL TRIAL OF KN026 IN COMBINATION WITH HB1801 FOR THE FIRST-LINE TREATMENT OF HER2-POSITIVE METASTATIC BC
2023-07-28
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
2023-07-06
RESIGNATION OF A NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF THE STRATEGY COMMITTEE
2023-06-30
AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
2023-06-12
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 12, 2023
2023-06-12
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
2023-06-06
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES ON KN026 IN COMBINATION WITH KN046 FOR PRESENTATION AT 2023 ASCO ANNUAL MEETING
2023-06-06
6
7
8
9
10
11
12
PREV
9/27
NEXT